PP> Vol.7 No.10, October 2016

Department of Infection Control and Prevention, Aichi Medical University School of Medicine, Nagakute, Japan
Department of Pharmacy, Aichi Medical University School of Medicine, Nagakute, Japan
Department of Infection Control and Prevention, Aichi Medical University School of Medicine, Nagakute, Japan
Department of Pharmacy, Aichi Medical University School of Medicine, Nagakute, Japan
Department of Infection Control and Prevention, Aichi Medical University School of Medicine, Nagakute, Japan
Department of Infection Control and Prevention, Aichi Medical University School of Medicine, Nagakute, Japan
Department of Infection Control and Prevention, Aichi Medical University School of Medicine, Nagakute, Japan
Department of Pharmacy, Aichi Medical University School of Medicine, Nagakute, Japan
Department of Infection Control and Prevention, Aichi Medical University School of Medicine, Nagakute, Japan

 

Copyright © 2016 Hideo Kato, Mao Hagihara, Yuka Yamagishi, Yukihiro Hamada, Jun Hirai, Naoya Nishiyama, Yusuke Koizumi, Katsuhiko Matsuura, Hiroshige Mikamo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article

---

Kato, H. , Hagihara, M. , Yamagishi, Y. , Hamada, Y. , Hirai, J. , Nishiyama, N. , Koizumi, Y. , Matsuura, K. and Mikamo, H. (2016) Is Dose Adjustment Based on Several Factors of Body Size Descriptors Effective for Prevention of Thrombocytopenia by Linezolid Therapy in Hemodialysis Patients?. Pharmacology & Pharmacy, 7, 417-423. doi: 10.4236/pp.2016.710049.

 

Download citation as EndNote